Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s388846 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Juan Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology & Cancer Center, ZhongShan Hospital, Fudan University, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Fasting, Protein Kinase Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology & Cancer Center, ZhongShan Hospital, Fudan University, Shanghai, People's Republic of China.
- Department of Pharmacy, Shanghai Children's Medical Center, School of Medicine, Shanghai JiaoTong University, Shanghai, People's Republic of China.
- Haihe Biopharma Co., Ltd, Shanghai, People's Republic of China.
ORCID-Profile: Juan Wu, Chao Liu, Xuening Li
Zitieren
APA
Wu, J., Xu, H., Li, H., Ma, L., Chen, J., Yuan, F., Sheng, L., Liu, C., Chen, W., & Li, X. (2023). Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s388846
Vancouver
Wu J, Xu H, Li H, Ma L, Chen J, Yuan F, et al. Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s388846
BibTeX
@article{Wu2023,
author = {Wu, Juan and Xu, Hongrong and Li, Hui and Ma, Lei and Chen, Juan and Yuan, Fei and Sheng, Lei and Liu, Chao and Chen, Weili and Li, Xuening},
title = {Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s388846}
}
EUVIMED